famotidine has been researched along with Central Nervous System Disease in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimoto, K | 1 |
| Saima, S | 1 |
| Echizen, H | 1 |
| Nakamura, Y | 1 |
| Kondo, T | 1 |
| Yagishita, Y | 1 |
| Ishizaki, T | 1 |
1 review available for famotidine and Central Nervous System Disease
| Article | Year |
|---|---|
Famotidine-associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure.
Topics: Aged; Aged, 80 and over; Central Nervous System Diseases; Famotidine; Female; Hematoma, Subdural; Hu | 1994 |